BlackRock Japan’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

BlackRock Japan’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-868	Closed	-$5K	–	1407
2016 Q2	$5K	Sell	868 -810	-48%	-$5.16K	﹤0.01%	1344
2016 Q1	$10K	Hold	1,678	–	–	﹤0.01%	1293
2015 Q4	$15K	Hold	1,678	–	–	﹤0.01%	1209
2015 Q3	$9K	Buy	+1,678	New	+$13.8K	﹤0.01%	1184
2015 Q1	–	Sell	-1,873	Closed	-$28K	–	1368
2014 Q4	$28K	Sell	1,873 -5,461	-74%	-$66.3K	﹤0.01%	1178
2014 Q3	$79K	Buy	7,334 +6,477	+756%	+$84.6K	﹤0.01%	984
2014 Q2	$13K	Sell	857 -212	-20%	-$3.05K	﹤0.01%	1185
2014 Q1	$19K	Sell	1,069 -652	-38%	-$12.6K	﹤0.01%	1284
2013 Q4	$24K	Buy	+1,721	New	+$19.8K	﹤0.01%	1205

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BlackRock Japan's SGMO Position: Q3 2016 in Review

BlackRock Japan sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2016, closing a stake of 868 shares — an estimated $5K sold.

BlackRock Japan first reported a position in SGMO in Q4 2013 and held it in 9 quarters. The position peaked at $79K in Q3 2014. 124 funds tracked by Wall St. Rank hold SGMO as of Q3 2016.

BlackRock Japan reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
BlackRock Japan sold 868 SANGAMO THERAPEUTICS INC shares in Q3 2016, an estimated $5K.
BlackRock Japan first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 9 quarters.
BlackRock Japan's SANGAMO THERAPEUTICS INC position peaked at $79K in Q3 2014.
124 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2016.

Based on BlackRock Japan's 13F filing for Q3 2016, filed 8 Nov 2016.